Multiple Myeloma
Multiple Myeloma
Advertisement
Rebecca AraujoSNMMI 2025 | June 13, 2025
Thirty percent of myeloma lytic bone lesions are not detected via FGD PET, demonstrating the need for improved visualization.
Read More
Heather KnoxBlood Cancers | June 9, 2025
Patients in the Northeast showed the highest age-adjusted cardiovascular mortality rate.
Rebecca AraujoMultiple Myeloma | May 6, 2025
Factors such as long travel times to access care or limited parking options were reported as barriers to care.
Heather KnoxBlood Cancers | May 5, 2025
A drug used to treat some types of leukemia may offer patients with refractory multiple myeloma a new avenue for treatment.
Tamara ThomasBlood Cancers | February 16, 2025
Persistent or newly developed lymphopenia after diagnosis was also linked to an increased risk of mortality.
Tamara ThomasColorectal Cancer | February 12, 2025
Individuals living in lower-income areas experience disproportionately higher rates of late-stage diagnoses and mortality.
Tamara ThomasMultiple Myeloma | January 24, 2025
responding physicians (92%) reported that prior authorization causes treatment delays for their patients
Tamara ThomasASH 2024 | February 13, 2025
The proportion of myeloma cases linked to BMI and diabetes was higher in Black patients than White patients.
Tamara ThomasASH 2024 | November 30, 2024
Patients who were Black or female were more likely to refuse treatment for multiple myeloma.
Rebecca AraujoASH 2024 | November 27, 2024
The study looked at disparities in outcomes of infusion with ide-cel or cilta-cel in patients with relapsed or refractory MM.
Cailin ConnerMultiple Myeloma | September 5, 2024
Significant delays in diagnosing multiple myeloma exist.
Cailin ConnerMultiple Myeloma | September 3, 2024
Talquetamab is a promising treatment for relapsed multiple myeloma, however, it presents unique side effects.
Cailin ConnerMultiple Myeloma | September 1, 2024
In MM patients, prescription delays were linked to Black race, older age, inpatient diagnosis, and severe renal impairment.
Cailin ConnerMultiple Myeloma | August 30, 2024
There is a disproportionately high MM incidence and mortality among non-Hispanic Black Americans.
Sikander Ailawadhi, MDMultiple Myeloma | July 29, 2024
Dr. Ailawadhi explores ways that researchers are designing trials to address racial disparities in enrollment.
Sikander Ailawadhi, MDMultiple Myeloma | July 24, 2024
Dr. Ailawadhi explained how oncologists should consider racial differences when approaching clinical care.
Rebecca AraujoMultiple Myeloma | July 8, 2024
Inpatient treatment comprised 48% of medical costs in patients with renal impairment.
Cailin ConnerMultiple Myeloma | July 3, 2024
Patients with multiple myeloma in the US Military Health System had significantly better survival rates.
Rebecca AraujoMultiple Myeloma | June 24, 2024
Race was associated with the dollar amount patients were willing to pay for treatment each month.
Cailin ConnerMultiple Myeloma | June 22, 2024
Obesity significantly increases the risk of multiple myeloma, especially in Black populations.
Advertisement
Advertisement
Latest News

June 15, 2025